z-logo
open-access-imgOpen Access
Auraptene ameliorates osteoporosis by inhibiting RANKL/NFATc1 pathway-mediated bone resorption based on network pharmacology and experimental evaluation
Author(s) -
Mi H. Kim,
La Yoon Choi,
Jae Yoon Chung,
Eun-Jung Kim,
Woong Mο Yang
Publication year - 2022
Publication title -
bone and joint research
Language(s) - English
Resource type - Journals
ISSN - 2046-3758
DOI - 10.1302/2046-3758.115.bjr-2021-0380.r1
Subject(s) - rankl , ovariectomized rat , osteoporosis , bone mineral , medicine , endocrinology , bone resorption , osteoclast , bone remodeling , alkaline phosphatase , chemistry , activator (genetics) , receptor , biochemistry , estrogen , enzyme

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here